SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Library > White / Technical Paper

Selecting a dosage form for delivery to the lungs

Format: PDF file | Document type: White / Technical Paper
Related applications: Contract Manufacturing
REC130

Selecting and developing an appropriate dosage form for inhalation products can be challenging. The physicochemical properties of the API, the required dose, the target patient population, timeline and budget are all important considerations.

Other factors, such as biopharmaceutics, intellectual property, marketing and the competitive landscape, may also be relevant. Download Recipharm’s free inhalation whitepaper here for all you need to know when selecting an appropriate dosage form for drug delivery to the lungs.

LATEST CONTENT FROM Recipharm AB

Take steps to stay in the serialization race

As the deadline for drug serialization in the EU looms closer, it’s time to put the topic firmly on your agenda. Learn how to overcome the serialization challenge and simplify compliance.

Developing a new high throughput screen method to improve excipient selection for solubilisation

A new high throughput screen method designed to improve the efficiency of testing excipients to solubilise compounds could save companies time, money and resource.

Supplier's Info Centre

Recipharm AB